These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 36498710)
21. Pulmonary hypertension due to left heart disease: The prognostic implications of diastolic pulmonary vascular pressure gradient. Ibe T; Wada H; Sakakura K; Ikeda N; Yamada Y; Sugawara Y; Mitsuhashi T; Ako J; Fujita H; Momomura S J Cardiol; 2016 Jun; 67(6):555-9. PubMed ID: 26299611 [TBL] [Abstract][Full Text] [Related]
22. Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18 mm Hg: insights from the REVEAL Registry. Frost AE; Farber HW; Barst RJ; Miller DP; Elliott CG; McGoon MD Chest; 2013 Jan; 143(1):185-195. PubMed ID: 22661451 [TBL] [Abstract][Full Text] [Related]
23. [Pulmonary arterial hypertension: modern diagnostics and therapy--Part 1]. Betkier-Lipińska K; Ryczek R; Kwasiborski P; Cwetsch A Pol Merkur Lekarski; 2013 Jun; 34(204):355-9. PubMed ID: 23882936 [TBL] [Abstract][Full Text] [Related]
24. A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats. Sang P; Kucherenko MM; Yao J; Li Q; Simmons S; Kuebler WM; Knosalla C J Vis Exp; 2022 Mar; (181):. PubMed ID: 35311828 [TBL] [Abstract][Full Text] [Related]
25. Pulmonary Hypertension with Valvular Heart Disease: When to Treat the Valve Disease and When to Treat the Pulmonary Hypertension. Martinez C; Tsugu T; Sugimoto T; Lancellotti P Curr Cardiol Rep; 2019 Nov; 21(12):151. PubMed ID: 31768665 [TBL] [Abstract][Full Text] [Related]
26. Pulmonary hypertension associated with left heart disease. Maron BA; Bortman G; De Marco T; Huston JH; Lang IM; Rosenkranz SH; Vachiéry JL; Tedford RJ Eur Respir J; 2024 Oct; 64(4):. PubMed ID: 39209478 [TBL] [Abstract][Full Text] [Related]
27. Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension. Richter MJ; Tiede SL; Sommer N; Schmidt T; Seeger W; Ghofrani HA; Schermuly R; Gall H PLoS One; 2016; 11(11):e0165982. PubMed ID: 27802345 [TBL] [Abstract][Full Text] [Related]
29. Plasma levels of high density lipoprotein cholesterol and outcomes in chronic thromboembolic pulmonary hypertension. Khirfan G; Tejwani V; Wang X; Li M; DiDonato J; Dweik RA; Smedira N; Heresi GA PLoS One; 2018; 13(5):e0197700. PubMed ID: 29813091 [TBL] [Abstract][Full Text] [Related]
30. Under pressure: pulmonary hypertension associated with left heart disease. Farber HW; Gibbs S Eur Respir Rev; 2015 Dec; 24(138):665-73. PubMed ID: 26621980 [TBL] [Abstract][Full Text] [Related]
31. Pulmonary hypertension associated with left-sided heart disease. Maeder MT; Schoch OD; Kleiner R; Joerg L; Weilenmann D; Swiss Society For Pulmonary Hypertension Swiss Med Wkly; 2017; 147():w14395. PubMed ID: 28102878 [TBL] [Abstract][Full Text] [Related]
32. Study of the Characteristics of Pulmonary Trunk in Pulmonary Hypertension Secondary to Left Heart Disease Using Pressure-Velocity Loops (PU-Loops). Hanya S; Yoshii K; Sugawara M Ann Vasc Dis; 2017 Sep; 10(3):197-204. PubMed ID: 29147168 [No Abstract] [Full Text] [Related]
33. Machine learning to differentiate pulmonary hypertension due to left heart disease from pulmonary arterial hypertension. Swinnen K; Verstraete K; Baratto C; Hardy L; De Vos M; Topalovic M; Claessen G; Quarck R; Belge C; Vachiery JL; Janssens W; Delcroix M ERJ Open Res; 2023 Sep; 9(5):. PubMed ID: 37727672 [TBL] [Abstract][Full Text] [Related]
34. Clinical-imaging-pathological correlation in pulmonary hypertension associated with left heart disease. van de Veerdonk MC; Roosma L; Trip P; Gopalan D; Vonk Noordegraaf A; Dorfmüller P; Nossent EJ Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38417969 [TBL] [Abstract][Full Text] [Related]
35. Non-invasive screening using ventilatory gas analysis to distinguish between chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension. Akizuki M; Sugimura K; Aoki T; Kakihana T; Tatebe S; Yamamoto S; Sato H; Satoh K; Shimokawa H; Kohzuki M Respirology; 2020 Apr; 25(4):427-434. PubMed ID: 31261445 [TBL] [Abstract][Full Text] [Related]
36. Pulmonary Arterial Capacitance Predicts Cardiac Events in Pulmonary Hypertension Due to Left Heart Disease. Sugimoto K; Yoshihisa A; Nakazato K; Jin Y; Suzuki S; Yokokawa T; Misaka T; Yamaki T; Kunii H; Suzuki H; Saitoh SI; Takeishi Y PLoS One; 2016; 11(11):e0165603. PubMed ID: 27875533 [TBL] [Abstract][Full Text] [Related]
37. Pulmonary hypertension in Portugal: first data from a nationwide registry. Baptista R; Meireles J; Agapito A; Castro G; da Silva AM; Shiang T; Gonçalves F; Robalo-Martins S; Nunes-Diogo A; Reis A Biomed Res Int; 2013; 2013():489574. PubMed ID: 24228252 [TBL] [Abstract][Full Text] [Related]
38. Critical appraisal of the instantaneous end-diastolic pulmonary arterial wedge pressures. Manouras A; Lund LH; Gellér L; Nagy AI; Johnson J ESC Heart Fail; 2020 Dec; 7(6):4247-4255. PubMed ID: 33021347 [TBL] [Abstract][Full Text] [Related]
39. Long-term survival in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Insights from a referral center in Portugal. Santos M; Gomes A; Cruz C; Rocha J; Ricardo M; Gonçalves F; Carvalho L; Vicente M; Melo A; Reis A Rev Port Cardiol (Engl Ed); 2018 Sep; 37(9):749-757. PubMed ID: 30144959 [TBL] [Abstract][Full Text] [Related]
40. Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease. Huston JH; Shah SJ Circ Res; 2022 Apr; 130(9):1382-1403. PubMed ID: 35482841 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]